| Literature DB >> 24475280 |
Kengo Maekawa1, Tomoko Baba2, Sumi Otomo2, Shoji Morishita3, Nobushige Tamura4.
Abstract
OBJECTIVES: Postoperative cognitive dysfunction (POCD) is recognized as a complication in the elderly after cardiac surgery. Imaging of the brain provides evidence of neurodegeneration in elderly patients; however, abnormalities in brain structure and their relation to POCD are uncertain. This pilot study investigated whether loss of gray matter in the bilateral medial temporal lobe (MTL), seen in preoperative MRI, was associated with POCD.Entities:
Mesh:
Year: 2014 PMID: 24475280 PMCID: PMC3903674 DOI: 10.1371/journal.pone.0087375
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Voxel-based based specific regional analysis for Alzheimer's disease (VSRAD) analysis in a 78-year-old woman before aortic valve replacement (A) and a 68-year-old man before mitral valve repair (B).
VSRAD provides a color-scaled Z score map ranging from 2.0 to 6.0 with overlaid orthogonal sections of an anatomically standardized brain template. (A) Axial VSRAD and its enlarged image at 20 mm. Gray matter was lost in the medial temporal lobe. The Z score was 3.1. (B) In contrast, there was no gray matter change in the medial temporal lobe preoperatively. Z score was 0.3.
Neuropsychological Results for Patients with and without Postoperative Cognitive Dysfunction.
| Cognitive domain | Instrument | POCD n = 8 | No POCD n = 20 |
|
| Composite measure |
| |||
| preoperative | 26.8±1.9 | 26.9±1.9 | 0.902 | |
| follow-up | 24.4±2.1 | 26.8±3.0 | 0.050 | |
| Δ | −2.4±1.7 | −0.1 ±2.4 | 0.024 | |
| Verbal memory |
| |||
| preoperative | 8.1±1.1 | 7.1±1.7 | 0.132 | |
| follow-up | 8.1±1.7 | 6.9±1.9 | 0.109 | |
| Δ | 0.0 ±1.3 | −0.3 ±1.1 | 0.604 | |
|
| ||||
| preoperative | 5.5±1.3 | 4.6±1.4 | 0.121 | |
| follow-up | 5.0±1.6 | 4.4±1.4 | 0.302 | |
| Δ | −0.5±1.3 | −0.3±1.2 | 0.624 | |
| Complex attention |
| |||
| preoperative | 32.8±8.3 | 32.6±12.9 | 0.976 | |
| follow-up | 22.6±8.1 | 34.0±12.0 | 0.022 | |
| Δ | −10.1±4.8 | 1.4±4.4 | 0.001 | |
|
| ||||
| preoperative | 68.8±32.8 | 59.7±28.5 | 0.473 | |
| follow-up | 94.1±49.9 | 62.2±25.0 | 0.031 | |
| Δ | 25.4±38.9 | 2.5 ±13.4 | 0.026 | |
| Executive function |
| |||
| preoperative | 22.6±8.2 | 23.8±10.7 | 0.782 | |
| follow-up | 14.4±8.0 | 27.7±12.6 | 0.011 | |
| Δ | −8.3±4.3 | 3.9±5.4 | 0.001 | |
|
| ||||
| preoperative | 189±75 | 173±102 | 0.690 | |
| follow-up | 298±170 | 179±89 | 0.023 | |
| Δ | 109±102 | 6.6±42 | 0.001 | |
MMSE = Mini-Mental State Examination.
Change between preoperative and follow-up test scores.
Prevalence of Gray Matter Loss in the Medial Temporal Lobe, Intracranial and Carotid Artery Stenosis, and Atherosclerosis of the Ascending Aorta.
| POCD n = 8 | No POCD n = 20 |
| |
|
| 2.0±0.9 | 1.1±0.9 | 0.027 |
| Hardly any gray matter loss | 1 (12) | 13 (65) | 0.044 |
| Some gray matter loss | 3 (38) | 4 (20) | |
| Considerable gray matter loss | 3 (38) | 1 (5) | |
| Prominent gray matter loss | 1 (12) | 2 (10) | |
|
| |||
| Absence | 3 (38) | 9 (45) | 0.028 |
| Punctate foci | 0 | 6 (30) | |
| Beginning confluence of foci | 1 (12) | 4 (20) | |
| Large confluent areas | 4 (50) | 1 (5) | |
|
| |||
| No infarcts | 4 (50) | 17 (85) | 0.149 |
| Single infarct | 1 (12) | 1 (5) | |
| Multiple infarcts, single location | 3 (38) | 2 (10) | |
| Multiple infarcts, multiple location | 0 | 0 | |
|
| |||
| Normal or mild | 8 (100) | 19 (95) | 1.000 |
| Moderate | 0 | 0 | |
| Severe | 0 | 1 (5) | |
|
| |||
| Normal or mild | 8 (100) | 19 (95) | 1.000 |
| Moderate | 0 | 1 (5) | |
| Severe | 0 | 0 | |
|
| |||
| Normal or mild | 5 (63) | 17 (85) | 0.424 |
| Moderate | 1 (12) | 1 (5) | |
| Severe | 2 (25) | 2 (10) |
MTL = medial temporal lobe; MRI = magnetic resonance imaging; MRA = magnetic resonance angiography.
Characteristics of Patients with and without Postoperative Cognitive Dysfunction.
| POCD n = 8 (29%) | No POCD n = 20 |
| |
| Age (years) | 75.9±8.1 | 71.4±7.2 | 0.159 |
| ≥75 | 5 (63) | 5 (25) | 0.136 |
| 65≤74 | 2 (25) | 13 (65) | |
| Gender (male/female) | 6/2 | 13/7 | 1.000 |
| Education (years) | 12.6±3.0 | 10.3±2.2 | 0.028 |
| Hypertension | 5 (63) | 15 (75) | 0.651 |
| Diabetes mellitus | 3 (37) | 6 (30) | 1.000 |
| Peripheral arterial disease | 1 (13) | 1 (5) | 0.497 |
| History of atrial fibrillation | 4 (50) | 5 (25) | 0.372 |
| Ejection fraction | 59.6±12.6 | 65.8±14.2 | 0.297 |
| Preoperative medications | |||
| Aspirin | 5 (63) | 13 (65) | 1.000 |
| Statins | 4 (50) | 9 (45) | 1.000 |
| β-blockers | 4 (50) | 6 (30) | 0.400 |
| Surgical procedure | |||
| CABG | 1 (13) | 8 (40) | 0.061 |
| CABG/Valvular | 3 (37) | 1 (5) | |
| Valvular | 4 (50) | 11 (55) | |
| CPB time (min) | 202±57 | 183±74 | 0.529 |
| Cross-clamp time (min) | 116±34 | 119±41 | 0.861 |
Continuous variables are presented as mean ± SD and categorical variables are presented as frequency (percentage). CABG = coronary artery grafting; CPB = cardiopulmonary bypass.